BioMADE, a collaboration of public and private enterprise pursuing the manufacturing of "high-value" chemicals, materials, ...

LIfT BioSciences, (LIfT), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, announces progress in advancing the planned clinical trial for their Immunomodulatory Alpha ...

The delay for Stealth Biotherapeutics comes amid a heightened focus on the impact FDA job cuts might have on drug reviews.

Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...

A $132 million manufacturing campus — where companies will transform crops into industrial chemicals otherwise made with petroleum and often sourced from overseas — is coming to Maple Grove. The ...

Sutter said it denied any wrongdoing but agreed to the sizable settlement to avoid the burden, distraction and expense of ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

The emerging biotech scene in Chicago has the potential to develop new treatments and technologies, but funding cuts from the ...

LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland ...

Every day brings new technological developments that affect every aspect of our lives, writing the future. New developments ...

The National Security Commission on Emerging Biotechnology (NSCEB) announced on April 8, 2025, the availability of its final ...